tiprankstipranks
Trending News
More News >
Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market

Repare Therapeutics (RPTX) Financial Statements

Compare
448 Followers

Repare Therapeutics Financial Overview

Repare Therapeutics's market cap is currently $109.06M. The company's EPS TTM is $0.08; its P/E ratio is -1.49; Repare Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 53.48M$ 51.13M$ 131.83M$ 7.60M$ 135.00K
Gross Profit$ 40.10M$ 37.89M$ 15.11M$ -80.25M$ -38.64M
Operating Income$ -93.52M$ -116.22M$ -19.80M$ -108.66M$ -54.30M
EBITDA$ -90.22M$ -114.27M$ -17.82M$ -107.19M$ -53.41M
Net Income$ -84.69M$ -93.80M$ -29.05M$ -106.91M$ -53.42M
Balance Sheet
Cash & Short-Term Investments$ 152.79M$ 223.63M$ 343.94M$ 341.87M$ 333.71M
Total Assets$ 176.51M$ 253.90M$ 364.07M$ 368.71M$ 357.09M
Total Debt$ 1.93M$ 3.41M$ 5.43M$ 7.31M$ 4.00M
Net Debt$ -82.78M$ -107.86M$ -154.09M$ -327.11M$ -322.18M
Total Liabilities$ 25.38M$ 41.82M$ 84.56M$ 80.29M$ 70.26M
Stockholders' Equity$ 151.13M$ 212.08M$ 279.52M$ 288.42M$ 286.83M
Cash Flow
Free Cash Flow$ -76.44M$ -129.10M$ -280.00K$ -87.49M$ -8.32M
Operating Cash Flow$ -76.44M$ -127.16M$ 322.00K$ -85.80M$ -6.08M
Investing Cash Flow$ 49.47M$ 78.04M$ -175.78M$ -1.68M$ -9.76M
Financing Cash Flow$ 542.00K$ 842.00K$ 880.00K$ 95.56M$ 247.84M
Currency in USD

Repare Therapeutics Earnings and Revenue History

Repare Therapeutics Debt to Assets

Repare Therapeutics Cash Flow

Repare Therapeutics Forecast EPS vs Actual EPS